Alzheimer's Disease Trial, Recruiting NCT07672171 Sponsor: Juin-Hong Cherng Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07672171
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Alzheimer's disease dementia
  • People whose memory and thinking test score (called an MMSE score) falls between 18 and 24 out of 30
  • People who are currently taking dementia medication and have been on a steady, unchanged dose
  • People who have normal ability to feel temperature changes on their skin
  • People whose legal representative is willing and able to sign a consent form before the trial begins, or people who are able to sign it themselves

Who may not be able to join:

  • People whose dementia is caused by something other than Alzheimer's disease, such as vascular dementia, Lewy body dementia, or frontotemporal dementia
  • People who are known to be sensitive or allergic to heat or light, or who are currently taking medications that increase sensitivity to light
  • People whose ability to feel heat or temperature is reduced, for example due to taking painkillers, sedatives, or regularly drinking alcohol
  • People with a current acute injury, active inflammation, infection, or open wounds
  • People with certain active or acute circulatory or joint conditions, including blood clots in a vein, varicose veins, severe blockage of arteries in the limbs, lymphatic disease, active rheumatoid arthritis, active gout, or a current fever
  • People with patchy redness or other unusual skin conditions on the scalp or neck
  • People with skin lesions, skin damage, or open wounds where the trial device would make contact with the body
  • People who are currently taking part in another clinical trial
  • People with any other health condition that a doctor determines would make participation unsafe (confirm with trial site)
  • People who are unwilling or unable to sign the required consent form
  • People who are unable or unwilling to follow the trial schedule, procedures, or required check-up appointments
  • People who have a history of, or currently have, a bleeding or blood clotting disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jiunn-Tay Lee, M.D., Trial-Service General Hospital, National Defense Medical University

Phone: 886-2-87923100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Juin-Hong Cherng
Registry
ClinicalTrials.gov
Start date
15 October 2022
Est. completion
31 October 2029

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Number of Participants With Yin Fu Rui De Far-Infrared Therapy Device-Related Adverse Events (AEs); Number of Participants With Yin Fu Rui De Far-Infrared Therapy Device-Related Serious Adverse Events (SAEs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov